{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:10:28Z","timestamp":1760235028898,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: In recent years, the observed frequency of hospitalization of patients taking mephedrone with other psychoactive substances has increased. There are no data in the literature on the effect of mephedrone use on liver function in patients, including the frequency of HCV infection. We have analysed the impact of taking mephedrone together with other psychoactive substances on the incidence of HCV infection. We have also analysed the effect of taking mephedrone with heroin, alcohol, and benzodiazepines on liver enzyme levels. Methods: The study included patients taking mephedrone with: alcohol (n = 115), heroin (n = 85) and benzodiazepines (n = 130) hospitalized in 2010\u20132018. The control group consisted of patients addicted to alcohol (n = 180), heroin (n = 221) and benzodiazepines (n = 152). Clinical data and laboratory findings were collected from medical records. Results: Taking mephedrone together with benzodiazepines is a statistically significant predictor of HCV infection in this group of patients, OR (8.44); 95% CI 5.63\u201312.64; p &lt; 0.001). A statistically significant interaction of the group with HCV infection was observed, i.e., for the level of alanine transaminase (p &lt; 0.001) and aspartate transaminase (p &lt; 0.001). Increased levels of liver enzymes in each of the studied groups was characteristic in patients with HCV infection (p &lt; 0.001). Taking additional mephedrone by this group of patients did not increase the level of liver enzymes. Conclusion: HCV infection is a statistically significant factor affecting the increase in liver enzymes levels in the group of patients taking mephedrone.<\/jats:p>","DOI":"10.3390\/jcm10153218","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:53:23Z","timestamp":1626868403000},"page":"3218","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychoactive Substances Taken with Mephedrone and HCV Infection"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-4397","authenticated-orcid":false,"given":"Michal","family":"Ordak","sequence":"first","affiliation":[{"name":"Department of Pharmacodynamics, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeusz","family":"Nasierowski","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Muszynska","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bujalska-Zadrozny","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(19)32231-7","article-title":"New psychoactive substances: Challenges for drug surveillance, control, and public health responses","volume":"394","author":"Peacock","year":"2019","journal-title":"Lancet"},{"key":"ref_2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2015). New Psychoactive Substances in Europe, Publications Officece of the European Union. Available online: http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_235958_EN_TD0415135ENN.pdf."},{"key":"ref_3","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2018, February 03). EMCDDA\u2014Europol 2017 Annual Report on the Implementation of Council Decision 2005\/387\/JHA. Available online: http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/9282\/20183924_TDAN18001ENN_PDF.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcp.14183","article-title":"How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances","volume":"86","author":"Corkery","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(16)30258-6","article-title":"Mephedrone use is increasing in London","volume":"387","author":"Hockenhull","year":"2016","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2215-0366(18)30305-5","article-title":"The growing problem of mephedrone use in Warsaw, Poland, 2010\u201318","volume":"5","author":"Ordak","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"ref_7","unstructured":"(2010). The Council of the European Union. Council decision of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) tocontrol measures. Off. J. Eur. Union."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fpsyt.2017.00306","article-title":"Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats","volume":"8","author":"Pinterova","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/bph.12628","article-title":"The preclinical pharmacology of mephedrone; not just MDMA by another name","volume":"171","author":"Green","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxlet.2018.11.007","article-title":"Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay","volume":"301","author":"Richter","year":"2019","journal-title":"Toxicol. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11845-010-0636-6","article-title":"Acute liver failure following recreational use of psychotropic \u201chead shop\u201d compounds","volume":"180","author":"Frohlich","year":"2011","journal-title":"Ir. J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tox.2017.06.004","article-title":"Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones","volume":"387","author":"Luethi","year":"2017","journal-title":"Toxicology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","article-title":"Public health and international drug policy","volume":"387","author":"Csete","year":"2016","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/jhep.2001.25759","article-title":"Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco","volume":"34","author":"Hahn","year":"2001","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.3748\/wjg.v23.i20.3569","article-title":"Hepatitis C in injection drug users: It is time to treat","volume":"23","author":"Grassi","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.11.006","article-title":"HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary\u2014An expanding public health burden","volume":"41","author":"Wiessing","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3748\/wjg.v22.i4.1411","article-title":"Alcoholic liver disease and hepatitis C virus infection","volume":"22","author":"Chamorro","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11481-014-9577-6","article-title":"Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs","volume":"10","author":"Zhou","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00705-013-1627-5","article-title":"HCV infection among cocaine users in the state of Par\u00e1, Brazilian Amazon","volume":"158","author":"Sawada","year":"2013","journal-title":"Arch. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2105\/AJPH.2016.303090","article-title":"Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs","volume":"106","author":"Bach","year":"2016","journal-title":"Am. J. Public Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2019.01.008","article-title":"Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus","volume":"66","author":"McAuley","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13651501.2019.1682172","article-title":"Optimisation of methadone treatment in a group of patients on a mephedrone binge and dependent on many psychoactive substances","volume":"24","author":"Ordak","year":"2020","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gittins, R., Guirguis, A., Schifano, F., and Maidment, I. (2018). Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK. Brain Sci., 8.","DOI":"10.3390\/brainsci8040058"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E2606","DOI":"10.1002\/hup.2606","article-title":"The risk of violence associated with novel psychoactive substance use in patients presenting to acute mental health services","volume":"32","author":"Shafi","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jemermed.2012.07.061","article-title":"Synthetic Cannabinoid Intoxication: A Case Series and Review","volume":"44","author":"Harris","year":"2013","journal-title":"J. Emerg. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugpo.2012.01.008","article-title":"\u201cA Costly Turn On\u201d: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors","volume":"23","author":"Bingham","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"ref_28","unstructured":"(2020). European Drug Report 2020: Trends and Developments. Emcdda, Lisbon, September 2020, Publications Office of the European Union. Available online: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13236\/TDAT20001ENN_web.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1521-0391.2013.12058.x","article-title":"Hepatitis C infection in non-treatment-seeking heroin users: The burden of cocaine injection","volume":"22","author":"Roux","year":"2013","journal-title":"Am. J. Addict."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004836-200303000-00012","article-title":"Hepatitis C and Alcohol: Interactions, outcomes, and implications","volume":"36","author":"Bhattacharya","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.addbeh.2009.09.012","article-title":"Combined effects of alcohol and hepatitis C: A secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence","volume":"35","author":"Plebani","year":"2010","journal-title":"Addict. Behav."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2015.07.017","article-title":"Benzodiazepine use as an independent risk factor for HIV infection in a Canadian setting","volume":"155","author":"Ickowicz","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/162.4.823","article-title":"Prevalence, incidence, and risk factors of hepatitis C virus infec-tion. Among drug users in Amsterdam","volume":"162","author":"Goudsmit","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1080\/10826080701212550","article-title":"Characterization of Former Heroin Addict Patients With Hepatitis C Virus Antibodies in a Methadone Maintenance Treatment (MMT) Clinic in Israel","volume":"42","author":"Peles","year":"2007","journal-title":"Subst. Use Misuse"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1360-0443.2011.03719.x","article-title":"Cognitive and subjective effects of mephedrone and factors influencing use of a \u2018new legal high\u2019","volume":"107","author":"Freeman","year":"2012","journal-title":"Addiction"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fpsyt.2020.00755","article-title":"The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","article-title":"Interventions for reducing benzodiazepine use in older people: Meta-analysis of randomised controlled trials","volume":"204","author":"Gould","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Arends, R.M., Nelwan, E.J., Soediro, R., Van Crevel, R., Alisjahbana, B., Pohan, H.T., Von Borries, A.K.L., Schene, A.H., Van Der Ven, A.J.A.M., and Schellekens, A. (2019). Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0207970"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.psychres.2016.04.114","article-title":"Risk-taking behavior and impulsivity among HCV-infected patients","volume":"243","author":"Nunes","year":"2016","journal-title":"Psychiatry Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e25360","DOI":"10.1002\/jia2.25360","article-title":"Hepatitis C virus elimination: Time for disruptive innovation","volume":"22","author":"Klein","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4254\/wjh.v10.i2.186","article-title":"Hepatitis C virus: Morphogenesis, infection and therapy","volume":"10","author":"Morozov","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4254\/wjh.v7.i10.1377","article-title":"Hepatitis C virus: Virology, diagnosis and treatment","volume":"7","author":"Li","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0029-1214374","article-title":"Hepatitis C virus and alcohol","volume":"29","author":"Siu","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/CLEP.S162308","article-title":"Hepatitis C infection substantially reduces survival of alcohol-dependent patients","volume":"10","author":"Muga","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JABB\/2016\/22047","article-title":"Effect of Heroin Use on Liver Enzymes","volume":"5","author":"Farooqi","year":"2016","journal-title":"J. Adv. Biol. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1360-0443.2012.04043.x","article-title":"Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication","volume":"107","author":"McNicholas","year":"2012","journal-title":"Addiction"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/15\/3218\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:03Z","timestamp":1760164383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/15\/3218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":48,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["jcm10153218"],"URL":"https:\/\/doi.org\/10.3390\/jcm10153218","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}